Ameriprise’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Buy |
|
|||||
|
2025
Q2 | $6.15M | Buy |
|
|||||
|
2025
Q1 | $684K | Sell |
|
|||||
|
2024
Q4 | $618K | Sell |
|
|||||
|
2024
Q3 | $1.36M | Buy |
|
|||||
|
2024
Q2 | $1.19M | Sell |
|
|||||
|
2024
Q1 | $5.39M | Buy |
|
|||||
|
2023
Q4 | $4.68M | Sell |
|
|||||
|
2023
Q3 | $66.2M | Buy |
|
|||||
|
2023
Q2 | $67.9M | Buy |
|
|||||
|
2023
Q1 | $53.5M | Buy |
|
|||||
|
2022
Q4 | $54.8M | Buy |
|
|||||
|
2022
Q3 | $55.2M | Buy |
|
|||||
|
2022
Q2 | $54.2M | Sell |
|
|||||
|
2022
Q1 | $50.3M | Sell |
|
|||||
|
2021
Q4 | $51.8M | Buy |
|
|||||
|
2021
Q3 | $46.7M | Sell |
|
|||||
|
2021
Q2 | $55.4M | Buy |
|
|||||
|
2021
Q1 | $55.2M | Buy |
|
|||||
|
2020
Q4 | $39.7M | Buy |
|
|||||
|
2020
Q3 | $26.1M | Sell |
|
|||||
|
2020
Q2 | $69.2M | Buy |
|